Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599118 · ClinicalTrials.gov registry record
Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
A clinical trial of Atrial Fibrillation, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 1,300
- Enrollment target
- 1
- Study location
NCT00599118: Active study of Atrial Fibrillation, sponsored by The Cleveland Clinic.
NCT00599118 is a study of Atrial Fibrillation that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 1,300 participants, below the 2,990-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00599118, a study of Atrial Fibrillation, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish a genebank repository of blood samples and data to generate information about the hereditary (genetic) basis of atrial fibrillation.
Primary Outcome
Genome-wide association study of atrial fibrillation
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinical Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2005-08 |
| Est. Completion | 2035-12 |
What the registry record for NCT00599118 still lists
NCT00599118 is an observational study that tracks outcomes without assigning an intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, below the 2,990-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT00599118 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00599118 about?
NCT00599118 is a clinical study titled "Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation". The purpose of this study is to establish a genebank repository of blood samples and data to generate information about the hereditary (genetic) basis of atrial fibrillation.
What is the current status of trial NCT00599118?
This trial is currently active not recruiting. The enrollment target is 1,300 participants. The study started on 2005-08. Estimated completion is 2035-12.
What conditions does trial NCT00599118 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
Who is sponsoring clinical trial NCT00599118?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00599118 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00599118's enrollment target sits among peer trials
1,300 35th of 202 higher than 168 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia